PAEDIATRIC MENTAL HELP FOR CHILDREN OF DEFENCE PERSONNEL, VETERANS AND FIRST RESPONDERS Psychosocial research translated into teaching resources
Filmed in Armidale, New South Wales | November 2024
Dr Marg Rogers is a Senior Lecturer in Early Childhood Education at University of New England (UNE) in Armidale, New South Wales. She is a prominent figure in early childhood education New South Wales, and is also a Post Doctoral Fellow at the Manna Institute, a mental health research organisation within the regional university network across Australia, that is building place based research capacity to improve the mental health of regional, rural and remote Australia.
Dr Rogers has taught across all areas of education: early childhood, primary, secondary and tertiary. She researches marginalised voices within families and education, especially in regional, rural and remote communities.
Many Australian Defence Force (ADF) members reside in rural, regional, and remote (RRR) communities, creating significant challenges for their families regarding mental health service access. With 30% of current ADF members living in these areas, families often endure waiting lists for specialised care, which is typically located in metropolitan settings. As a result, children in these families frequently witness trauma, leading to potential mental health issues.
Australian Health Journal spoke with Dr Rogers on her research focusing on paediatric mental health, specifically developing early intervention psychosocial resources for children from veterans, defence families, and first responders.
Dr. Rogers emphasises the need for increased support and resources for these families, advocating for flexible, accessible care that moves with them, including telehealth options. Her work includes developing printed and digital storybooks based on children’s narratives to help families cope with issues like moral injury.
The impact of her work, has also garnered interest overseas, in collaborative efforts with Canadian and UK institutions who are further enhancing these resources for affected families in their own countries.
-
Cardiovascular Disease Risk Guidance and Calculator get long overdue update
Cardiovascular disease (CVD) is responsible for significant morbidity and premature mortality in Australia. Ischaemic heart disease was the leading cause of death in 2020 and cerebrovascular disease was the third most common cause of death.
As the first major update to Australian CVD risk assessment guidelines in over a decade, the 2023 Australian Guideline for assessing and managing cardiovascular disease risk and associated Aus CVD Risk Calculator reflect the latest evidence on assessing, communicating, and managing CVD risk. Developed using Australian-specific data and the latest evidence, it supersedes the 2012 Guidelines for the management of absolute cardiovascular disease risk.
-
Recognising service in health regulation
In April 2023, Professor John Skerritt retired from his position of Deputy Secretary Health Products Regulation Group, a role he has been in since 2012. During his time at the TGA he had line responsibility for over 1200 staff involved in the regulation of therapeutic goods, regulation of gene technology and industrial chemicals and control of drug import, export and production.
At this year’s ARCS 2023 Conference, ARCS Australia CEO Dr Shanny Dyer paid tribute to Professor Skerritt and his service to the Australian health industry. She led a tribute with fellow industry heads, Elizabeth de Somer, CEO, Medicines Australia, Anne Harris, Managing Director, Pfizer Australia & New Zealand, Deon Schoombie, CEO, Consumer Healthcare Products Australia, Ian Burgess, CEO, Medical Technology Association of Australia and Arthur Brandwood, President ARCS Australia.
-
Funding roadblocks creating digital health inequity
Helen Souris, CEO and Executive Director of Cardihab and Chair of the Digital Health Advisory Group at the Medical Technology Association of Australia (MTAA), highlights the significant gap in cardiac rehabilitation access across Australia. Despite the proven benefits of cardiac rehabilitation in improving survival, quality of life, and reducing hospital admissions, around 80% of eligible patients do not receive this care, with access rates even lower in regional and rural communities.
